Should you forget Eli Lilly and buy this magnificent biotech instead? Let's find out.

Rekha Rakesh Jhunjhunwala, through multiple discretionary trusts, owned 25,199,240 equity shares, or 24.09 per cent stake in ...

It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...

Mankind Pharma announced the pledge of nearly 40 per cent of its wholly-owned subsidiary, Bharat Serums and Vaccines Limited, ...

Some Bayer investors say CEO Bill Anderson should speed up turnaround efforts, including boosting efficiency and drug ...

JB Pharma, Sun, Torrent ,Lupin, Abbott, Glenmark, Dr Reddy’s Cipla, Zydus remained among Key pharma market growth drivers in ...

Amidst October's volatile stock market and a dip in the Nifty, Indian fund managers focused on long-term growth sectors. They ...

Donald Trump has nominated vaccine sceptic Robert Kennedy Jr as the nation’s top health official in another unconventional ...

Donald Trump's nomination of Robert F Kennedy Jr. to lead the Department of Health and Human Services sent shares of major ...

Enterprise software juggernaut Microsoft, like most tech stocks, had started September on the wrong foot. Microsoft stock ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, ...